" class="no-js "lang="en-US"> mRNA Archives - Medtech Alert
Tuesday, September 02, 2025

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development

Providence Therapeutics, a biopharmaceutical company developing messenger RNA (mRNA) vaccines and therapeutics, today announced its […]

TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion

TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, […]

BioCina Has Been Awarded Grants to Develop mRNA Vaccines

BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it […]

Strand Therapeutics Appoints Colleen Wilson as Chief People Officer

Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, today […]

Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics

Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement on […]

Nutcracker Therapeutics Demonstrates Immunotherapeutic Potency of Lead mRNA Candidate

Nutcracker Therapeutics, a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology […]

Strand Therapeutics Presents Preclinical Data on Programmable mRNA Therapy STX-001 at AACR 2023

Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, announced […]

ReCode Therapeutics Announces First Participants Dosed in a Healthy Volunteer Clinical Trial for the Treatment of Primary Ciliary Dyskinesia

ReCode Therapeutics, a private, clinical-stage genetic medicines company using superior delivery to power the next […]

Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy

Porton Advanced and DanausGT Biotechnology have announced a strategic collaboration in gene and cell therapy […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more